| Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer A Sharp, I Coleman, W Yuan, C Sprenger, D Dolling, DN Rodrigues, ... The Journal of clinical investigation 129 (1), 192-208, 2019 | 334 | 2019 |
| Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer Z Zhang, WR Karthaus, YS Lee, VR Gao, C Wu, JW Russo, M Liu, ... Cancer Cell 38 (2), 279-296. e9, 2020 | 167 | 2020 |
| Transcriptional mediators of treatment resistance in lethal prostate cancer MX He, MS Cuoco, J Crowdis, A Bosma-Moody, Z Zhang, K Bi, A Kanodia, ... Nature medicine 27 (3), 426-433, 2021 | 112 | 2021 |
| Expression of PD-L1 in hormone-naïve and treated prostate cancer patients receiving neoadjuvant abiraterone acetate plus prednisone and leuprolide C Calagua, J Russo, Y Sun, R Schaefer, R Lis, Z Zhang, K Mahoney, ... Clinical Cancer Research 23 (22), 6812-6822, 2017 | 90 | 2017 |
| CCN5: biology and pathophysiology JW Russo, JJ Castellot Journal of cell communication and signaling 4, 119-130, 2010 | 68 | 2010 |
| Neoadjuvant-intensive androgen deprivation therapy selects for prostate tumor foci with diverse subclonal oncogenic alterations AG Sowalsky, H Ye, M Bhasin, EM Van Allen, M Loda, RT Lis, ... Cancer research 78 (16), 4716-4730, 2018 | 61 | 2018 |
| Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors A Richters, SK Doyle, DB Freeman, C Lee, BS Leifer, S Jagannathan, ... Cell chemical biology 28 (2), 134-147. e14, 2021 | 55 | 2021 |
| Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture J Russo, HD Soule, C McGrath, MA Rich Journal of the National Cancer Institute 56 (2), 279-280, 1976 | 53 | 1976 |
| Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer JW Russo, C Gao, SS Bhasin, OS Voznesensky, C Calagua, S Arai, ... Cancer research 78 (22), 6354-6362, 2018 | 51 | 2018 |
| Androgen receptor and MYC equilibration centralizes on developmental super-enhancer H Guo, Y Wu, M Nouri, S Spisak, JW Russo, AG Sowalsky, MM Pomerantz, ... Nature communications 12 (1), 7308, 2021 | 43 | 2021 |
| Gleason score 7 prostate cancers emerge through branched evolution of clonal Gleason pattern 3 and 4 AG Sowalsky, HT Kissick, SJ Gerrin, RJ Schaefer, Z Xia, JW Russo, ... Clinical Cancer Research 23 (14), 3823-3833, 2017 | 43 | 2017 |
| Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer X Liu, Y Gao, HH Ye, S Gerrin, F Ma, Y Wu, T Zhang, J Russo, C Cai, ... Nucleic acids research 45 (7), 3738-3751, 2017 | 38 | 2017 |
| CCN5, a secreted protein, localizes to the nucleus KC Wiesman, L Wei, C Baughman, J Russo, MR Gray, JJ Castellot Journal of cell communication and signaling 4, 91-98, 2010 | 31 | 2010 |
| Fatty acid ethyl esters in liver and adipose tissues as postmortem markers for ethanol intake RO Salem, MA Refaai, JE Cluette-Brown, JW Russo, M Laposata Clinical chemistry 47 (4), 722-725, 2001 | 30 | 2001 |
| Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer JW Russo, X Liu, H Ye, C Calagua, S Chen, O Voznesensky, J Condulis, ... Cancer letters 438, 97-104, 2018 | 24 | 2018 |
| Androgen receptor interaction with mediator complex is enhanced in castration-resistant prostate cancer by CDK7 phosphorylation of MED1 JW Russo, M Nouri, SP Balk Cancer discovery 9 (11), 1490-1492, 2019 | 22 | 2019 |
| Autocrine canonical Wnt signaling primes noncanonical signaling through ROR1 in metastatic castration-resistant prostate cancer F Ma, S Arai, K Wang, C Calagua, AR Yuan, L Poluben, Z Gu, JW Russo, ... Cancer research 82 (8), 1518-1533, 2022 | 18 | 2022 |
| CCN5 in alveolar epithelial proliferation and differentiation during neonatal lung oxygen injury N Fiaturi, JW Russo, HC Nielsen, JJ Castellot Journal of Cell Communication and Signaling 12, 217-229, 2018 | 17 | 2018 |
| Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells J Liang, L Wang, L Poluben, M Nouri, S Arai, L Xie, OS Voznesensky, ... Cancer letters 519, 172-184, 2021 | 16 | 2021 |
| Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer AG Sowalsky, I Figueiredo, RT Lis, I Coleman, B Gurel, D Bogdan, ... Clinical Cancer Research 28 (16), 3509-3525, 2022 | 12 | 2022 |
